Table 2 Summary of AE occurrence and concomitant medication use for women enrolled in PREGACT trial
Characteristic | AL | ASAQ | DHAPQ |
|---|---|---|---|
Total AEs | 475 | 569 | 468 |
AE drug-relatedness totals | |||
 Definitely not | 36 | 34 | 38 |
 Possibly/probably | 26 | 96 | 26 |
 Unlikely | 413 | 443 | 404 |
At least one AE, n (%) | 187 (64.5) | 205 (70.7) | 172 (59.3) |
Total concomitant medications | 1229 | 1033 | 1042 |
Median concomitant medications (IQR) | 3 (2, 5) | 3 (1, 4) | 3 (2, 5) |
At least one concomitant medication, n(%) | 287(99.0) | 287(99.0) | 287(99.0) |